Publications

The role of publics in the introduction of new vaccines.

PATERSON, P; LARSON, HJ;

2012

Health policy and planning, (2012).27 Sup Suppl 10.1093/heapol/czs038.

Blockade of IL-10 signaling during bacillus Calmette-Guérin vaccination enhances and sustains Th1, Th17, and innate lymphoid IFN-γ and IL-17 responses and increases protection to Mycobacterium tuberculosis infection.

Pitt, JM; Stavropoulos, E; Redford, PS; Beebe, AM; BANCROFT, GJ; Young, DB; O'Garra, A;

2012

Journal of immunology (Baltimore, Md, (2012).189 8 10.4049/jimmunol.1201061.

Serotype replacement after pneumococcal vaccination.

MULHOLLAND, K; Satzke, C;

2012

Lancet, (2012).379 9824 10.1016/S0140-6736(12)60588-1.

BCG vaccination in England since 2005: a survey of policy and practice.

PILGER, D; NGUIPDOP-DJOMO, P; ABUBAKAR, I; Elliman, D; RODRIGUES, LC; Watson, JM; Eastman, V; MANGTANI, P;

2012

BMJ open, (2012).2 5 10.1136/bmjopen-2012-001303.

Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine.

Horowitz, A; HAFALLA, JC R; KING, E; Lusingu, J; Dekker, D; Leach, A; Moris, P; Cohen, J; Vekemans, J; Villafana, T; CORRAN, PH; Bejon, P; DRAKELEY, CJ; Von Seidlein, L; RILEY, EM;

2012

Journal of immunology (Baltimore, Md, (2012).188 10 10.4049/jimmunol.1102710.

Addressing public questioning and concerns about vaccination in South Africa: a guide for healthcare workers.

Burnett, RJ; LARSON, HJ; Moloi, MH; Tshatsinde, EA; Meheus, A; PATERSON, P; François, G;

2012

Vaccine, (2012).30 Sup SUPPL. 10.1016/j.vaccine.2012.03.037.

Induction of strain-transcending antibodies against Group A PfEMP1 surface antigens from virulent malaria parasites.

Ghumra, A; Semblat, J-P; Ataide, R; Kifude, C; Adams, Y; Claessens, A; Anong, DN; Bull, PC; Fennell, C; Arman, M; AMAMBUA-NGWA, A; Walther, M; CONWAY, DJ; Kassambara, L; Doumbo, OK; Raza, A; Rowe, JA;

2012

PLoS pathogens, (2012).8 4 10.1371/journal.ppat.1002665.

Using the internet to estimate influenza vaccine effectiveness.

EDMUNDS, WJ; FUNK, S;

2012

Expert review of vaccines, (2012).11 9 10.1586/erv.12.88.

A new challenge for the tuberculosis vaccine community?.

DOCKRELL, HM;

2012

The Journal of infectious diseases, (2012).205 7 10.1093/infdis/jis016.

Influenza vaccination for immunocompromised patients: systematic review and meta-analysis by etiology.

Beck, CR; McKenzie, BC; Hashim, AB; HARRIS, RC; University of Nottingham Influenza and the ImmunoC,; Nguyen-Van-Tam, JS;